Mylan (MYL) Reports Herceptin Settlement and License Agreement with Genentech and Roche
Tweet Send to a Friend
Mylan N.V. (NASDAQ: MYL) today announced that Mylan has agreed to the terms of a global settlement with Genentech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
